Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bio-Techne Cp (TECH)

Bio-Techne Cp (TECH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,581,875
  • Shares Outstanding, K 38,609
  • Annual Sales, $ 738,690 K
  • Annual Income, $ 229,300 K
  • 60-Month Beta 1.13
  • Price/Sales 18.17
  • Price/Cash Flow 56.56
  • Price/Book 9.31
Trade TECH with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 1.22
  • Number of Estimates 3
  • High Estimate 1.23
  • Low Estimate 1.22
  • Prior Year 0.81
  • Growth Rate Est. (year over year) +50.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
308.66 +14.74%
on 12/21/20
361.47 -2.02%
on 01/20/21
+33.93 (+10.60%)
since 12/18/20
3-Month
250.24 +41.53%
on 10/30/20
361.47 -2.02%
on 01/20/21
+89.68 (+33.91%)
since 10/20/20
52-Week
155.17 +128.25%
on 03/23/20
361.47 -2.02%
on 01/20/21
+133.56 (+60.54%)
since 01/17/20

Most Recent Stories

More News
Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on , at to review second quarter 2021 financial results.

TECH : 355.31 (+1.00%)
Is Vaccine Stock Novavax Still a Buy?

Vaccine specialist Novavax (NVAX) has experienced a steep decline over the past couple of months owing to the delay in its COVID-19 vaccine development. Unfortunately, the delay comes at a time when its...

NVAX : 124.16 (-3.00%)
BNTX : 103.42 (-1.22%)
TECH : 355.31 (+1.00%)
ARWR : 83.00 (+1.03%)
Bio-Techne To Present At The 39th Annual J.P. Morgan Healthcare Conference

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that , President and Chief Executive Officer, will present at the 39 Annual J.P. Morgan Healthcare Conference on at . A live webcast...

JPM : 135.79 (-1.63%)
TECH : 355.31 (+1.00%)
Regulus Therapeutics Collaborates With Bio-Techne For Biomarker Development

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326,...

RGLS : 1.1600 (unch)
TECH : 355.31 (+1.00%)
Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies

, /PRNewswire/ -- Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (NASDAQ: RNLX), has received Emergency Use Authorization (EUA) from the U.S. Food and...

RNLX : 22.74 (+1.52%)
TECH : 355.31 (+1.00%)
Bio-Techne Corp Up 18.4% Since SmarTrend Uptrend Call (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on October 6th, 2020 at $255.38. In approximately 2 month, Bio-Techne Corp has returned 18.44% as of today's recent price of $302.47.

TECH : 355.31 (+1.00%)
Bio-Techne To Present At The Stephens Annual Investment Conference 2020

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that , President and Chief Executive Officer, will present at the Stephens Annual Investment Conference 2020 on at . A live webcast...

TECH : 355.31 (+1.00%)
Uptrend Call Working As Bio-Techne Corp Stock Rises 16.9% (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on October 6th, 2020 at $255.38. In approximately 1 month, Bio-Techne Corp has returned 16.95% as of today's recent price of $298.65.

TECH : 355.31 (+1.00%)
Techne (TECH) Q1 Earnings and Revenues Beat Estimates

Techne (TECH) delivered earnings and revenue surprises of 25.44% and 9.96%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

TECH : 355.31 (+1.00%)
Bio-Techne Releases First Quarter Fiscal 2021 Results

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended .

TECH : 355.31 (+1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

3rd Resistance Point 365.25
2nd Resistance Point 359.79
1st Resistance Point 355.78
Last Price 355.31
1st Support Level 346.31
2nd Support Level 340.85
3rd Support Level 336.84

See More

52-Week High 361.47
Last Price 355.31
Fibonacci 61.8% 282.66
Fibonacci 50% 258.32
Fibonacci 38.2% 233.98
52-Week Low 155.17

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar